You have admitted a haemodynamically unstable septic patient with acute renal failure and the following biochemistry:
Normal |
On Admission |
|
Na (mmol/L) |
135 – 145 |
133 |
K (mmol/L) |
3.5 – 4.5 |
6 |
Urea (mmol/L) |
3 – 8 |
50 |
Creatinine (umol/L) |
50 – 100 |
550 |
Phosphate (mmol/L) |
0.7 – 1.4 |
2.5 |
Lactate (mmol/L) |
0.2 - 2 |
8 |
The original viva from the college didn't give you a choice about CRRT, and was more interested in the choice of filter:
You have decided to initiate CVVHDF in a septic patient with acute renal failure and the following biochemistry:
Please choose the filter that you will use in a CVVHDF circuit for this patient? Name some advantages of the filter you have chosen?
The rest of the questions focused on circuit set up, discussion of pre-dilution, choice of dialysate, trouble shooting various alarms and interpretation of raised urea creatinine ratio.
Of course this viva relies heavily on a situation where the trainee walks into a room and finds the examiner sitting there, surrounded by different filters. This is not something that's likely to happen in the average viva practice group environment, at which these confabulated non-canonical vivas are aimed. Ergo, the author has taken extensive liberties with the original format. The trainee is given the option of not dialysing the patient, to see how they justify their position.
So, if they recommend early RRT, the following supporting rationale is valid:
If they decide to wait and watch:
Cardiovascular
Miscellaneous
|
Neurological
Endocrine
Gastrointestinal
Haematological
|
This is identical to Question 25 from the second paper of 2007:
Intra-renal Failure |
Pre-renal failure |
|
Urine osmolality |
Less than 400-450 mOsm/kg: concentrating ability is lost |
More than 450-500 mOsm/kg: concentrated urine is being passed. This demonstrated that concentrating capacity is preserved, |
Urine sodium |
High in ATN (>40 meq/L) due in part to the tubular injury. Injured tubules cannot concentrate urine or appropriately reabsorb sodium. |
Low in prerenal disease (<20 meq/L) in a (sometimes) appropriate attempt to conserve sodium. Pre-renal failure may also include various low-output or decreased renal blood flow states such as cirrhosis and CCF. |
Urea/ creatinine ratio |
Normal in ATN |
May be greater. In dehydration, urea is disproportionately elevated (indicating a loss of total body water). |
The ratio is calculated from US units, rather than the usual units. In the US, your creatinine is not 500μmol/L, its 0.5mmol/L. Urea remains in mmol/L. Thus, urea/creatinine gives you the ratio. Anything above 100 is considered abnormal (ie. too much urea and not enough creatinine). |
||
Urine/serum creatinine ratio |
More than 40 |
Less than 20 |
Urine/serum osmolality |
More than 1.0 |
More than 1.5 |
Fractional excretion of urea |
More than 25% |
Less than 25% |
Fractional excreton of sodium |
More than 2% (demonstrating a failure of sodium resorption) |
Less than 1% (demonstrating a tendency to conserve sodium, as if in a state of hypovolemia) |
|
||
Urine microscopy |
ATN:
|
|
The candidate should be allowed to ramble for a period.
This equation describes Jc, the convective flux:
Thus, the important elements are
The sieving coefficient is ":the ratio of a specific solute concentration in the ultrafiltrate (removed only by a convective mechanism), divided by the mean plasma concentration in the filter."
Also:
Pre-dilution | Post-dilution | |
Advantages |
|
|
Disadvantages |
|
|
Citrate |
|
|
Direct thrombin inhibitors: Hirudin / Lepirudin Bivalirudin / Argatroban |
|
|
Heparinoids (Danaparoid) |
|
|
Xa inhibitors: Fondaparinux |
|
|
Serine protease inhibitors: Nafamostat |
|
|
Prostacyclin (PGI2) |
|
|
Causes:
Troubleshooting:
"Transmembrane pressure is the hydrostatic pressure gradient across the membrane. This is the driving force that causes ultrafiltration."
Thus, TMP is the effluent pressure subtracted from the average of the pressures in the blood side of the circuit (which are the filter pressure and the return pressure). TMP tends to rise gradually over the course of the dialysis session, as the filter becomes clogged with filth.
The cardinal features of citrate toxicity are:
Disclaimer: the viva stem above may be an original CICM stem, acquired from their publicly available past papers. Or, perhaps it is a slightly altered version of the original CICM stem. Or, it is a completely original viva stem, concocted by the monstrously amoral author of Deranged Physiology for nothing more than his own personal amusement. In either case, because the college do not make the main viva text or marking criteria available, almost everything here has been confabulated. It might sound like a plausible viva and it could be used for the purpose of practice, but all should be aware that it does not represent the "true" canonical CICM viva station.
Gaudry, Stéphane, et al. "Initiation strategies for renal replacement therapy according to severity and septic shock: a post-hoc analysis of the AKIKI trial." D24. CRITICAL CARE: THE OTHER HALF OF THE ICU-UPDATE IN MANAGEMENT OF NON-PULMONARY CRITICAL CARE. American Thoracic Society, 2017. A7136-A7136.
Luo, Kaiping, et al. "The optimal time of initiation of renal replacement therapy in acute kidney injury: A meta-analysis." Oncotarget 8.40 (2017): 68795.
Wald, Ron, Martin Gallagher, and Sean M. Bagshaw. "Shedding new light on an old dilemma: two trials examining the timing of renal replacement therapy initiation in acute kidney injury." American Journal of Kidney Diseases 69.1 (2017): 14-17.
Sanjay Subramanian, John A. Kellum, and Claudio Ronco "Oliguria" in: Critical Care Nephrologyby Ronco, Bellomo and Kellum (2009) pp. 341
Crook, Martin. Case Presentations in Chemical Pathology. Elsevier, 2013.
Bagshaw, Sean M., Christoph Langenberg, and Rinaldo Bellomo. "Urinary biochemistry and microscopy in septic acute renal failure: a systematic review."American journal of kidney diseases 48.5 (2006): 695-705.
Vaara, Suvi T., et al. "Timing of RRT based on the presence of conventional indications." Clinical Journal of the American Society of Nephrology 9.9 (2014): 1577-1585.
Wierstra, Benjamin T., et al. "The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis." Critical Care 20.1 (2016): 1.
Gaudry, Stéphane, et al. "Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit." New England Journal of Medicine (2016).
Seabra, Victor F., et al. "Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis." American Journal of Kidney Diseases 52.2 (2008): 272-284.
Kleinknecht, Dieter, et al. "Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis." Kidney international 1.3 (1972): 190-196.
Egal, Mohamud, et al. "Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients: A Systematic Review and Meta-Analysis." Anesthesia & Analgesia 122.1 (2016): 173-185.
Ahmed, U. S., H. I. Iqbal, and S. R. Akbar. "Furosemide in Acute Kidney Injury–A Vexed Issue."Austin J Nephrol Hypertens 1.5 (2014): 1026.
Zarbock, Alexander, et al. "Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial."JAMA 315.20 (2016): 2190-2199.
Zhongping Huang, Jeffrey J. Letteri, Claudio Ronco, Dayong Gao, and William R. Clark "Predilution and Postdilution Reinfusion Techniques"; in: Critical Care Nephrology by Ronco, Bellomo and Kellum (2009) pp. 1370
Ronco, C., et al. "The haemodialysis system: basic mechanisms of water and solute transport in extracorporeal renal replacement therapies." Nephrology Dialysis Transplantation 13.suppl 6 (1998): 3-9.
Uchino, Shigehiko, et al. "Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control." Nephron Clinical Practice 94.4 (2004): c94-c98.
Nurmohamed, Shaikh A., et al. "Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin." ASAIO Journal 57.1 (2011): 48-52.